Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial Article Early Access

Industry Collaboration International Collaboration

cited authors

  • Cherney, David Z. I.; Cosentino, Francesco; Dagogo-Jack, Samuel; McGuire, Darren K.; Pratley, Richard E.; Frederich, Robert; Maldonado, Mario; Liu, Chih-Chin; Pong, Annpey; Cannon, Christopher P.

authors

Publication Date

  • June 10, 2022

webpage

published in

category

keywords

  • Clinical trial
  • Diabetic nephropathy
  • Glomerular filtration rate
  • Kidney function decline
  • Kidney protection
  • Sodium-glucose cotransporter 2 inhibitor
  • Type 2 diabetes mellitus